Antiestrogens in tumor therapy

A. Manni, O. H. Pearson

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


In the last decade a major advance in the treatment of breast cancer has been achieved with the introduction of antioestrogen therapy. The rationale behind this modality of treatment is to inhibit the peripheral action of oestrogens regardless of their circulating blood levels. This theoretically represents an advantage over endocrine ablative procedures which do not completely eliminate circulating oestrogens. It is the purpose of this paper to review the clinical use of the antioestrogen tamoxifen (Nolvadex®) in the management of advanced as well as early breast cancer. A summary will also be given on the use of tamoxifen in other malignancies.

Original languageEnglish (US)
Pages (from-to)65-75
Number of pages11
JournalClinics in Oncology
Issue number1
StatePublished - Jan 1 1982

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology


Dive into the research topics of 'Antiestrogens in tumor therapy'. Together they form a unique fingerprint.

Cite this